Benjamin F. Mcgraw III - 28 Feb 2022 Form 4 Insider Report for AERIE PHARMACEUTICALS INC

Role: Interim Executive Chair, Director
Signature: /s/ John LaRocca, Attorney-in-Fact for Benjamin F. McGraw
Issuer symbol: N/A
Transactions as of: 28 Feb 2022
Net transactions value: -$85,689
Form type: 4
Filing time: 02 Mar 2022, 16:38:42 UTC
Previous filing: 22 Sep 2021
Next filing: 13 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AERI	Common Stock	Tax liability	$85,689	-10,324	-22%	$8.30	35,739	28 Feb 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects shares of Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted Common Stock.

Remarks:

Reported transaction occurred on February 28, 2022, after which date the reporting person ceased to serve in the position of Interim Executive Chair. The reporting person continues to serve as a director as of the date of this filing.